FDA — authorised 31 March 2003
- Application: ANDA076025
- Marketing authorisation holder: BAUSCH
- Status: approved
🇺🇸 ipratroprium in United States
FDA authorised ipratroprium on 31 March 2003
Marketing authorisations
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is ipratroprium approved in United States?
Yes. FDA authorised it on 31 March 2003; FDA has authorised it.
Who is the marketing authorisation holder for ipratroprium in United States?
BAUSCH holds the US marketing authorisation.